A prospective randomized study on the use of nadroparin calcium in the prophylaxis of thromboembolism in Korean patients undergoing elective total hip replacement

被引：11

作者：

Yoo M.C. ^{[1
]}

Kang C.S. ^{[2
]}

Kim Y.H. ^{[3
]}

Kim S.K. ^{[4
]}

机构：

[1] Department of Orthopaedic Surgery, Kyung Hee University Hospital, Seoul 130-702, Hoeki-Dong Dongdaemun-ku

[2] Keimyung University, Dongsang Medical Center, Teague, 194, Dongsan-Dong

[3] Department of Orthopaedic Surgery, Hanyang University, Guri Hospital, Guri, Kyunggi-Do, 471-020, 249-1, Kyomoon-Dong

[4] Department of Orthopaedic Surgery, Korea University, Guro Hospital, Guro-Gu, Seoul, 152-020, 80, Guro-Dong

来源：

International Orthopaedics | 1998年 / 21卷 / 6期

关键词：

Deep Vein Thrombosis; Asian Patient; Korean Patient; Parmi; Nadroparin;

D O I：

10.1007/s002640050194

中图分类号：

学科分类号：

摘要：

because of the belief that post-operative deep vein thrombosis (DVT) is rare in Asian patients, thromboprophylaxis is not usually prescribed for surgical patients. This study reports an open multi-centre controlled study of the use of a low molecular weight heparin, nadroparin calcium (Fraxoparine Sanofi France), as opposed to no prophylaxis in 100 patients undergoing uncemented total hip replacement. The patients had bilateral venography performed preoperatively and 10 days after the operation. Eight patients (16%) developed DVT in the control group of 50 patients and 1 (2%) in the treatment group, also of 50 patients. Pulmonary embolus occurred in 1 patient in the treatment group and in 3 in the control group. Intraoperative and postoperative blood loss did not differ significantly between the two groups. Our study suggests that the incidence of DVT in Asian patients, though somewhat less than in their Western counterparts, is still considerable. It confirms the safety and efficacy of nadroparin calcium in preventing post-operative DVT in patients undergoing elective total hip replacement.

引用

页码：399 / 402

页数：3

共 11 条

[1]

Chau K.Y., Et al., An autopsy of pulmonary thromboembolism in Hong Kong Chinese, Pathology, 23, pp. 181-184, (1991)

[2]

Dhillon K.S., Askander A., Doraisamy S., Post-operative deep vein thrombosis in Asian patients is not a rarity, J Bone Joint Surg, 78, pp. 427-430, (1996)

[3]

Hull R., Et al., A comparison of subcutaneous low-molecular-weight heparin with warfarin sodium for prophylaxis against deep vein thrombosis after hip or knee implantation, N Engl J Med, 329, pp. 1370-1376, (1993)

[4]

Kim Y.H., Choi I.Y., Cho J.L., Deep vein thrombosis after uncemented total hip replacement, Proc 7th World Congress, (1996)

[5]

Kim Y.H., Suh J.S., Low incidence of deep vein thrombosis after cementless total hip replacement, J Bone Joint Surg, 70, pp. 878-881, (1988)

[6]

Levine M.N., Et al., Prevention of deep vein thrombosis after elective hip surgery: A randomized trial comparing low molecular weight heparin with standard unfractionated heparin, Ann Intern Med, 114, pp. 545-551, (1991)

[7]

Leyvraz P.F., Et al., Prevention of deep vein thrombosis after hip replacement: A randomized comparison between unfractionated heparin and low molecular weight heparin, BMJ, 303, pp. 543-548, (1991)

[8]

Mitra A.K., Khoo T.K., Ngan C.C.L., Deep vein thrombosis following hip surgery for fracture of the proximal femur, Sing Med J, 30, pp. 530-534, (1989)

[9]

Pareint G.D., Wessinger S.J., Harris W.H., Survey of prophylaxis against venous thromboembolism in adults undergoing hip surgery, Clin Orthop, 232, pp. 188-193, (1987)

[10]

Prevention of deep vein thrombosis with low molecular-weight heparin in patients undergoing total hip replacement, Arch Orthop Trauma Surg, 111, pp. 110-120, (1992)

← 1 2 →